MeriScreen Antigen Test

MERISCREEN COVID-19 ANTIGEN TEST KIT

MeriScreen COVID-19 Antigen Detection Check out is a speedy immunochromatographic assay examine for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal swab sample from a human physique.

Principle

COVID-19 Antigen Detection Check out is an immunoassay examine for fast and qualitative detection of SARS-CoV-2 an an infection from swab specimens. Monoclonal anti-SARS-CoV-2 antibodies are coated on the examine line space. Antigens of SARS-CoV-2, if present inside the specimens will work along with monoclonal antiSARS-CoV-2 antibodies conjugated with gold conjugate making antigen-antibodies conjugate superior. This superior migrates on the membrane by capillary movement, the place it should possible be captured by the monoclonal anti-SARS-CoV-2 antibody coated on the examine line. A colored examine line may very well be seen inside the consequence window if SARS-CoV-2 antigens are present inside the specimen. The depth of colored examine line will fluctuate relying upon the amount of SARS-CoV-2 antigen present inside the specimen.

SKU:NCTCAG-01

AVAILABILITY:Supplied Out

SHIPMENT:1 or 2 Working Days for Free

SIZE:25 Checks/Tools

SENSITIVITY:96.6%

SPECIFICITY:100%

Please Be Conscious:

Transient methodology of use of COVID-19 Ag Respi-Strip (CorisBioConcept):
1. The Nasopharyngeal and/or Oropharyngeal swab will in all probability be collected from COVID-19 suspect affected particular person in Viral Transport Medium (VTM).
2. The collected swab in VTM will in all probability be delivered to the laboratory in acceptable chilly chain circumstances.
3. As quickly because the sample is dropped on the laboratory, it will need to be handled in a BSL-2 diploma cabinet for aliquoting, putting in lysis buffer and loading the examine strip.
 Steps 1 & 2 will in all probability be carried out as per the same old observe adopted for assortment and transport of samples for COVID-19 RT-PCR examine.
 Step Three must be carried out as per producers’ instructions given with the examine tools.

Simple to Use

Individual-friendly interface; Requires no explicit expertise or in depth teaching.

Extreme Accuracy and Reliability

Wonderful sensitivity and specifi­metropolis as compared with molecular and viral custom methods.

Helpful Storage Selections

Small instrument dimension and room-temp storage applicable for any office or lab.

Lowered Individual Errors

QR code scanning routinely identifi­es the examine sort

Twin Testing Selections

Twin testing decisions allow for increased testing flexibility

CA153 (Cancer antigen) ELISA test
12	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen)

CA125 (Cancer antigen) ELISA test
11	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen)

CA50 (Cancer antigen) ELISA test
10	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of CA50 (Cancer antigen)

CEA (Cancer antigen) ELISA test
9	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of CEA (Cancer antigen)

NOVATest Antigen Rapid Test Kit (For Single Use) (NOVA Test)
nCov-500-01	Atlas Link Technology	1T	EUR 162

PSA (Prostate-specific antigen) ELISA test
8	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of PSA (Prostate-specific antigen)

NOVATest Antigen Rapid Kit (NOVA Test)
nCov-500	Atlas Link Technology	20 Tests	EUR 162

HEV-Ag hepatitis E antigen ELISA test
94	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of HEV-Ag hepatitis E antigen

SARS-CoV-2 Rapid Antigen Test Nasal
9901-NCOV-03G	Roche Diagnostics	25 Tests/Kit	EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

HBeAg hepatitis B E antigen ELISA test
79	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of HBeAg hepatitis B E antigen

SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-1	UnScience	1T	EUR 9.6
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-25	UnScience	25T/kit	EUR 42
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit
abx092096-20tests	Abbexa	20 tests	EUR 477.6

Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold)
abx092015-40tests	Abbexa	40 tests	EUR 518.4

Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold)
abx092016-40tests	Abbexa	40 tests	EUR 518.4

Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold)
abx092049-20tests	Abbexa	20 tests	EUR 276

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)
IOV87952	INVBIO	20T/kit	EUR 46.8
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Accu-Tell COVID-19 IgG/IgM Rapid Test
GEN-B352-20tests	Accu test	20 tests	EUR 283.2
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.

Accu-Tell COVID-19 IgG/IgM Rapid Test
GEN-B352-40tests	Accu test	40 tests	EUR 385.2
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus.